Capra Biosciences

Petrochemicals without the petroleum

Capra Biosciences is active in the climate tech space based in United States, founded in 2020.

Profile

Capra Biosciences is bringing down the biomanufacturing capex by greater than 10 times through our novel biofilm-based bioreactor design. Capra is taking on the fundamental problem that hindered market adoption of fermentation-produced biofuels in the early 2010s by eliminating the need for immense amounts of water and stainless steel. From bio-retinol to lubricants, Capra is bringing biological technoeconomics and scaling to make bio-derived products identical to and cost-competitive with their petrochemical analogs.

Capra Biosciences is positioned in climate tech, a segment that rewards a clear, focused offering.

The business is associated with United States.

The company is listed at the SOSV portfolio company stage of development.

Recorded headcount: 2-10 employees.

Public records show total funding of about $5K.

Website: caprabiosciences.com